No black box warning on record for Feirza 1/20

As of the latest FDA labeling reviewed, Feirza 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS USP, 1 MG/0.02 MG AND FERROUS FUMARATE TABLETS, 75 MG) does not carry a black box warning. Standard warnings and precautions still apply — see the full Feirza 1/20 medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence o

No black box warning on record for Feirza 1/20

Other warnings & precautions

WARNINGS The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence o

Feirza 1/20 Black Box Warning

No black box warning on record for Feirza 1/20

Other warnings & precautions

Feirza 1/20 Black Box Warning

No black box warning on record for Feirza 1/20

Other warnings & precautions